Literature DB >> 29948309

Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation.

Julie C Fitzgerald1,2, Michelle E Ross3, Neal J Thomas4, Scott L Weiss5, Fran Balamuth6,7, Amanda Hyre Anderson3.   

Abstract

BACKGROUND: Little data exist on acute kidney injury (AKI) risk factors in pediatric sepsis. We identified risk factors and inpatient outcomes associated with AKI at sepsis recognition in children with severe sepsis.
METHODS: Retrospective, cross-sectional study with inpatient outcome description of 315 patients > 1 month to < 20 years old with severe sepsis in a pediatric intensive care unit over 3 years. Exposures included demographics, vitals, and laboratory data. The primary outcome was kidney disease: Improving Global Outcomes creatinine-defined AKI within 24 h of sepsis recognition. Factors associated with AKI and AKI severity were identified using multivariable Poisson and multinomial logistic regression, respectively.
RESULTS: AKI was present in 42% (133/315) of severe sepsis patients, and 26% (83/315) had severe (stage 2/3) AKI. In multivariable-adjusted analysis, hematologic/immunologic comorbidities, malignancies, chronic kidney disease (CKD), abdominal infection, admission illness severity, and minimum systolic blood pressure (SBP) ≤ 5th percentile for age and sex within 24 h of sepsis recognition were associated with AKI. Factors associated with mild AKI were CKD and abdominal infection, while factors associated with severe AKI were younger age, hematologic/immunologic comorbidities, malignancy, abdominal infection, and minimum SBP ≤ 5th percentile. Patients with AKI had increased hospital mortality (17 vs. 8%, P = 0.02) and length of stay [median 20 (IQR 10-47) vs. 16 days (IQR 7-37), P = 0.03].
CONCLUSIONS: In pediatric severe sepsis, AKI is associated with age, comorbidities, infection characteristics, and hypotension. Future evaluation of risk factors for AKI progression during sepsis is warranted to minimize AKI progression in this high-risk population.

Entities:  

Keywords:  Acute kidney injury; Child; Pediatric intensive care units; Risk factors; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29948309     DOI: 10.1007/s00467-018-3981-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Early postresuscitation hypotension is associated with increased mortality following pediatric cardiac arrest.

Authors:  Alexis A Topjian; Benjamin French; Robert M Sutton; Thomas Conlon; Vinay M Nadkarni; Frank W Moler; J Michael Dean; Robert A Berg
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

2.  Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock.

Authors:  Won Young Kim; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Crit Care       Date:  2011-06-28       Impact factor: 3.425

3.  Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium.

Authors:  David B Page; John P Donnelly; Henry E Wang
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

4.  Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units.

Authors:  M Poukkanen; S T Vaara; V Pettilä; K-M Kaukonen; A-M Korhonen; S Hovilehto; O Inkinen; R Laru-Sompa; T Kaminski; M Reinikainen; V Lund; S Karlsson
Journal:  Acta Anaesthesiol Scand       Date:  2013-05-28       Impact factor: 2.105

5.  Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis.

Authors:  Fran Balamuth; Scott L Weiss; Julie C Fitzgerald; Katie Hayes; Sierra Centkowski; Marianne Chilutti; Robert W Grundmeier; Jane Lavelle; Elizabeth R Alpern
Journal:  Pediatr Crit Care Med       Date:  2016-09       Impact factor: 3.624

6.  Modified RIFLE criteria in critically ill children with acute kidney injury.

Authors:  A Akcan-Arikan; M Zappitelli; L L Loftis; K K Washburn; L S Jefferson; S L Goldstein
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

7.  Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.

Authors:  Kevin J Downes; Carter Cowden; Benjamin L Laskin; Yuan-Shung Huang; Wu Gong; Matthew Bryan; Brian T Fisher; Stuart L Goldstein; Theoklis E Zaoutis
Journal:  JAMA Pediatr       Date:  2017-12-04       Impact factor: 16.193

8.  Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study.

Authors:  Omar Alkandari; K Allen Eddington; Ayaz Hyder; France Gauvin; Thierry Ducruet; Ronald Gottesman; Véronique Phan; Michael Zappitelli
Journal:  Crit Care       Date:  2011-06-10       Impact factor: 9.097

9.  Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes.

Authors:  Sang Heon Suh; Chang Seong Kim; Joon Seok Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Early acute kidney injury and sepsis: a multicentre evaluation.

Authors:  Sean M Bagshaw; Carol George; Rinaldo Bellomo
Journal:  Crit Care       Date:  2008-04-10       Impact factor: 9.097

View more
  8 in total

1.  PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock.

Authors:  Natalja L Stanski; Erin K Stenson; Natalie Z Cvijanovich; Scott L Weiss; Julie C Fitzgerald; Michael T Bigham; Parag N Jain; Adam Schwarz; Riad Lutfi; Jeffrey Nowak; Geoffrey L Allen; Neal J Thomas; Jocelyn R Grunwell; Torrey Baines; Michael Quasney; Bereketeab Haileselassie; Hector R Wong
Journal:  Am J Respir Crit Care Med       Date:  2020-04-01       Impact factor: 21.405

2.  Major Adverse Kidney Events in Pediatric Sepsis.

Authors:  Scott L Weiss; Fran Balamuth; Cary W Thurm; Kevin J Downes; Julie C Fitzgerald; Benjamin L Laskin
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-18       Impact factor: 8.237

3.  Impact of acute kidney injury and nephrotoxic exposure on hospital length of stay.

Authors:  Justin B Searns; Katja M Gist; John T Brinton; Kaci Pickett; James Todd; Meghan Birkholz; Danielle E Soranno
Journal:  Pediatr Nephrol       Date:  2020-01-15       Impact factor: 3.714

4.  Quality improvement goals for pediatric acute kidney injury: pediatric applications of the 22nd Acute Disease Quality Initiative (ADQI) conference.

Authors:  David T Selewski; David J Askenazi; Kianoush Kashani; Rajit K Basu; Katja M Gist; Matthew W Harer; Jennifer G Jetton; Scott M Sutherland; Michael Zappitelli; Claudio Ronco; Stuart L Goldstein; Theresa Ann Mottes
Journal:  Pediatr Nephrol       Date:  2021-01-12       Impact factor: 3.714

5.  Consensus acute kidney injury criteria integration identifies children at risk for long-term kidney dysfunction after multiple organ dysfunction syndrome.

Authors:  Stephen M Gorga; Erin F Carlton; Joseph G Kohne; Ryan P Barbaro; Rajit K Basu
Journal:  Pediatr Nephrol       Date:  2021-01-11       Impact factor: 3.651

Review 6.  A Precision Medicine Approach to Biomarker Utilization in Pediatric Sepsis-Associated Acute Kidney Injury.

Authors:  James D Odum; Hector R Wong; Natalja L Stanski
Journal:  Front Pediatr       Date:  2021-04-14       Impact factor: 3.418

Review 7.  Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies.

Authors:  Lindsey Murphy; Kelly Maloney; Lia Gore; Eliza Blanchette
Journal:  Integr Blood Press Control       Date:  2022-01-19

8.  Association of early hypotension in pediatric sepsis with development of new or persistent acute kidney injury.

Authors:  Julie C Fitzgerald; Michelle E Ross; Neal J Thomas; Scott L Weiss; Fran Balamuth; Marianne Chilutti; Robert W Grundmeier; Amanda Hyre Anderson
Journal:  Pediatr Nephrol       Date:  2020-07-25       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.